💥 Dragon Pharma

YK11

Substance: YK11
Price For: 100 tabs (10 mg/tab)
Brand: Dragon Pharma

$145.00

Select Shipping Options:

🌐 International (12-15 Days)
🇺🇸 U.S. Domestic (5-7 Days)

International

U.S. Domestic

Dragon Pharma YK11 10 mg

IDENTITYCompoundYK11
SubstanceYK11 Research Compound
Strength10 mg/tablet
FormOral Tablet
Class Myostatin Pathway Research Compound

PHARMACOLOGYCategory SARM-related Research Compound
AdministrationOral (PO)
ActivityAndrogen Receptor Interaction
Research ProfileFollistatin / Myostatin Pathway
Clinical StatusNot Approved Medicine

SAFETYHuman DataLimited
Liver RiskMonitoring Recommended
Hormonal SuppressionPossible
Lipid EffectsMonitor Blood Profile
PCTConsidered After Use

STORAGE & PACKAGEBrandDragon Pharma
Package100 Tablets
Strength10 mg/tablet
StorageDry Place Below 25°C
ProtectionProtect From Light & Moisture

DOSING INFORMATIONBeginner5–10 mg/day
Intermediate10–15 mg/day
Advanced15–20 mg/day
AdministrationOnce Daily Oral Use
Typical Duration6–8 weeks

BODYBUILDING USAGEGoalLean Mass Support
Training PhaseBulking / Recomposition
Usage TimeUsually 6–8 weeks
Daily TimingConsistent Daily Administration
MonitoringHormonal & Liver Markers

CYCLE FEATURESWeek 1–2Initial Adaptation Phase
Week 3–6Peak Training Response Period
Week 6–8Final Evaluation Phase
OnsetSeveral Weeks
StabilityDaily Oral Exposure

PCT PROTOCOLRequirementMay Be Needed
Start TimeAfter Discontinuation Period
DurationUsually 4 weeks
Recovery SupportSERM Based Medical Monitoring
MonitoringTotal Testosterone & LH/FSH

STACK COMPATIBILITYLean MassTraining + Nutrition Support
Recomposition Compatible Research Compounds
BulkingStructured Resistance Training
SupportHealth Monitoring
AvoidUncontrolled Combinations

MECHANISM OF ACTIONPrimary TargetAndrogen Receptor
Research PathwayMyostatin Regulation
ProteinPotential Muscle Signaling Effects
FollistatinResearch Association
ClassificationNon-Steroidal Compound

PHARMACOKINETICSRouteOral Administration
AbsorptionGastrointestinal Uptake
MetabolismHepatic Processing
ExposureDaily Administration Profile
Half-lifeHuman Data Not Established

CONTRAINDICATIONSLiverExisting Liver Disease
HormonesUntreated Endocrine Disorders
CardiacCardiovascular Risk Assessment
LipidsMonitor Cholesterol Profile
PregnancyNot Indicated

CHEMICAL PROFILECompoundYK11
FormulaC25H34N4O2
Molecular Weight406.56 g/mol
Class Research Myostatin Pathway Compound
CAS431579-34-9

OVERVIEW

YK11 is an experimental research compound associated with androgen receptor activity and myostatin pathway investigation. Dragon Pharma YK11 10 mg tablets are designed for research-oriented users interested in studying compounds related to muscle signaling, differentiation pathways, and performance-related biology.

POTENTIAL BENEFITS

Research interest in muscle growth signaling
Potential influence on myostatin-related pathways
Non-steroidal chemical structure
Oral tablet administration format
Used in bodybuilding research discussions
Potential lean mass research applications

POTENTIAL RISKS

Limited human safety data
Possible hormonal suppression
Potential liver enzyme changes
Possible cholesterol alterations
Unknown long-term effects
Not approved for medical treatment

PERFORMANCE PROFILE

Lean Mass Support

75%

Strength Support

70%

Recovery

65%

Water Retention

20%

Hormonal Impact

55%

WHAT IS DRAGON PHARMA?

Dragon Pharma is a pharmaceutical-style research and performance brand known among bodybuilding communities for producing a range of research compounds, supplements, and performance-related products.

The brand is commonly associated with standardized tablet and injectable product formats designed for bodybuilding-oriented markets. Product quality, authenticity, and regulatory status should always be independently verified because research compounds are not equivalent to approved pharmaceutical medicines.

WHY CHOOSE DRAGON PHARMA

Recognized bodybuilding market presence
Consistent product presentation
Tablet format for convenient administration
Clear strength labeling
Wide range of performance-related products
Suitable for research discussion and educational content

CONCLUSION

Dragon Pharma YK11 10 mg represents an experimental oral research compound associated with androgen receptor activity and investigation of myostatin-related pathways. Unlike approved anabolic medications, YK11 lacks extensive human clinical research, meaning safety, effectiveness, and long-term outcomes remain uncertain.

For bodybuilding readers, YK11 is primarily discussed as a research compound related to lean mass development, strength support, and muscle signaling mechanisms. Responsible users should prioritize laboratory monitoring, health assessment, and awareness of the regulatory status of research chemicals.

Unlike traditional anabolic steroids, YK11 is not classified as a testosterone ester or approved pharmaceutical medication. Available information comes primarily from laboratory studies and limited preclinical research rather than large human clinical trials.

Scientific information regarding YK11 continues to evolve, and future research may provide additional understanding of its pharmacological properties.

DISCLAIMER

This content is provided exclusively for educational and informational purposes. YK11 is an experimental research compound and is not approved as a human pharmaceutical treatment. This information does not constitute medical advice, diagnosis, or endorsement of non-medical use.